Insmed Inc reports results for the quarter ended December 31 - Earnings Summary

Insmed

20/02/2025 20:11

* Insmed Inc  INSM.OQ  reported a quarterly adjusted loss of
$1.31​​ per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of
$-1.28.  The mean expectation of fourteen analysts for the
quarter was for a loss of $1.16 per share. Wall Street expected
results to range from $-1.39 to $-1.03 per share.
    * Revenue rose 24.8% to $104.44 million from a year ago;
analysts
expected $102.81 million. 
    * Insmed Inc's reported EPS for the quarter was a loss of
$1.31​.
    * The company reported a quarterly loss of $235.55 million.
    * Insmed Inc shares had risen by 21.4% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 17 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Insmed Inc is
$92.00 
This summary was machine generated from LSEG data February 20 at
08:10 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -1.16          -1.31          Missed
 Sep. 30 2024      -1.22          -1.27          Missed
 Jun. 30 2024      -1.27          -1.94          Missed
 Mar. 31 2024      -1.23          -1.06          Beat